According to the Economist Intelligence Unit (EIU) report ‘Asia-Pacific Personalised Health Index 2020’ developed by the Copenhagen Institute for Future Studies in partnership with Roche, India with a score of 36 was ranked at 10 out of 11 Asia Pacific Countries in terms of adopting personalised healthcare & steps taken to provide right care to the needed person at the right time. Singapore topped the Index followed by Taiwan & Japan at 2nd & 3rd positions respectively.
- The Index is a first-of-its-kind policy tool that provides a unique overview of the personalised health readiness of 11 health systems across Asia-Pacific.
- The 11 countries in the Asia Pacific region which were measured in the index are Australia, China, Japan, India, Indonesia, Malaysia, Singapore, South Korea, Taiwan, Thailand and New Zealand.
- Indonesia has been ranked at the 11th position.
Position | Country | Overall Score |
---|---|---|
10 | India | 36 |
1 | Singapore | 71 |
2 | Taiwan | 67 |
3 | Japan | 64 |
Indicators:
The index measures the performance of countries in 4 categories called ‘Vital Signs’ through 27 indicators.
The 4 Vital signs are
- Health Information Indicator – Measures data, infrastructure, and technical expertise which drive the growth of personalized healthcare.
- Health Services Indicators – Measures Planning, organization & Delivery of services in the personalized healthcare.
- Personalized Technologies Indicator – Measures devices, applications, platforms & reimbursement structures which boost personalized healthcare based on needs of concerned people.
- Policy Context Indicator – Measures Policies, Frameworks, partnerships, peoples & drivers which boost personalized healthcare.
India’s Rankings in other Indicators:
- India is placed at 10th Rank based on the health information indicator.
- Based on the Health services indicator, India has been ranked at 11th.
- Under Personalised Technologies Indicator, it has been ranked at 9th position.
- It has come at 5th Position in the Policy Context Indicator.
Singapore has topped the overall list due to its efficient national strategies, strong digital infrastructure & expanding innovation capacities.
Recent Related News:
i.On December 8, 2020, ADB approved USD 300 million (about Rs 2,200 crore) loan for Strengthening Comprehensive Primary Health Care in Urban Areas Program in India.
About Roche:
Chief Executive Officer (CEO) – Severin Schwan
Headquarters – Basel, Switzerland.
About Economist Intelligence Unit (EIU):
Managing Director – Robin Bew
HeadQuarter – London, United Kingdom